Oct 18, 2019 - Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
Oct 16, 2019 - Abbott Laboratories. (NYSE:ABT) Q3 2019 Results Earnings Conference Call October 16, 2019, 09:00 AM ET Company Participants Scott Leinenweber - VP, IR, Licensing and Acquisitions Miles White - Chairma
Oct 16, 2019 - ABT earnings call for the period ending September 30, 2019.
Oct 16, 2019 - In September of 2017, medical device company Abbott Labs (ABT) launched a new glucose monitoring sys
Oct 15, 2019 - Abbott (ABT) collaborates with Omada Health to revolutionize diabetes care by expanding technological access.
Oct 09, 2019 - Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 02, 2019 - The regulatory go-ahead for Abbott's (ABT) ARCHITECT STAT High Sensitivity Troponin-I blood test is a major stride forward in its commitment for detecting patients suspected of having a heart attack.
Oct 01, 2019 - Abbott (ABT) is upbeat about the latest clearance in its neuromodulation product portfolio.
Sep 20, 2019 - The FDA authorization classifies the new type of CGM devices in class II and subjects these to certain criteria called special controls.
Sep 18, 2019 - Abbott (ABT) aims to offer better treatment options for the most vulnerable patient population.